Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds

被引:43
作者
Menyailo, Maxim E. [1 ]
Tretyakova, Maria S. [1 ]
Denisov, Evgeny V. [1 ]
机构
[1] Russian Acad Sci, Lab Canc Progress Biol, Canc Res Inst, Tomsk Natl Res Med Ctr, Tomsk 634009, Russia
基金
俄罗斯科学基金会;
关键词
breast cancer; circulating tumor cells; heterogeneity; metastasis; FACTOR PATHWAY INHIBITOR; PERIPHERAL-BLOOD; ADVANCED PROSTATE; CULTURE-SYSTEMS; IN-VITRO; CAPTURE; SURVIVAL; CLUSTERS; STEM; CULTIVATION;
D O I
10.3390/ijms21051696
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metastasis being the main cause of breast cancer (BC) mortality represents the complex and multistage process. The entrance of tumor cells into the blood vessels and the appearance of circulating tumor cells (CTCs) seeding and colonizing distant tissues and organs are one of the key stages in the metastatic cascade. Like the primary tumor, CTCs are extremely heterogeneous and presented by clusters and individual cells which consist of phenotypically and genetically distinct subpopulations. However, among this diversity, only a small number of CTCs is able to survive in the bloodstream and to form metastases. The identification of the metastasis-initiating CTCs is believed to be a critical issue in developing therapeutic strategies against metastatic disease. In this review, we summarize the available literature addressing morphological, phenotypic and genetic heterogeneity of CTCs and the molecular makeup of specific subpopulations associated with BC metastasis. Special attention is paid to the need for in vitro and in vivo studies to confirm the tumorigenic and metastatic potential of metastasis-associating CTCs. Finally, we consider treatment approaches that could be effective to eradicate metastatic CTCs and to prevent metastasis.
引用
收藏
页数:16
相关论文
共 132 条
[1]   Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy [J].
Aaltonen, Kristina E. ;
Novosadova, Vendula ;
Bendahl, Par-Ola ;
Graffman, Cecilia ;
Larsson, Anna-Maria ;
Ryden, Lisa .
ONCOTARGET, 2017, 8 (28) :45544-45565
[2]   Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells [J].
Abreu, Manuel ;
Cabezas-Sainz, Pablo ;
Pereira-Veiga, Thais ;
Falo, Catalina ;
Abalo, Alicia ;
Morilla, Idoia ;
Curiel, Teresa ;
Cueva, Juan ;
Rodriguez, Carmela ;
Varela-Pose, Vanesa ;
Lago-Leston, Ramon ;
Mondelo, Patricia ;
Palacios, Patricia ;
Moreno-Bueno, Gema ;
Cano, Amparo ;
Garcia-Caballero, Tomas ;
Angel Pujana, Miquel ;
Sanchez-Pinon, Laura ;
Costa, Clotilde ;
Lopez, Rafael ;
Muinelo-Romay, Laura .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
[3]   Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis [J].
Aceto, Nicola ;
Bardia, Aditya ;
Miyamoto, David T. ;
Donaldson, Maria C. ;
Wittner, Ben S. ;
Spencer, Joel A. ;
Yu, Min ;
Pely, Adam ;
Engstrom, Amanda ;
Zhu, Huili ;
Brannigan, Brian W. ;
Kapur, Ravi ;
Stott, Shannon L. ;
Shioda, Toshi ;
Ramaswamy, Sridhar ;
Ting, David T. ;
Lin, Charles P. ;
Toner, Mehmet ;
Haber, Daniel A. ;
Maheswaran, Shyamala .
CELL, 2014, 158 (05) :1110-1122
[4]   Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset [J].
Agnoletto, Chiara ;
Corra, Fabio ;
Minotti, Linda ;
Baldassari, Federica ;
Crudele, Francesca ;
Cook, William Joseph James ;
Di Leva, Gianpiero ;
D'Adamo, Adamo Pio ;
Gasparini, Paolo ;
Volinia, Stefano .
CANCERS, 2019, 11 (04)
[5]   Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients [J].
Aktas, Bahriye ;
Tewes, Mitra ;
Fehm, Tanja ;
Hauch, Siegfried ;
Kimmig, Rainer ;
Kasimir-Bauer, Sabine .
BREAST CANCER RESEARCH, 2009, 11 (04)
[6]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[7]  
Amirkhosravi A, 2002, THROMB HAEMOSTASIS, V87, P930
[8]   The role of tissue factor pathway inhibitor in tumor growth and metastasis [J].
Amirkhosravi, Ali ;
Meyer, Todd ;
Amaya, Mildred ;
Davila, Monica ;
Mousa, Shaker A. ;
Robson, Theresa ;
Francis, John L. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (07) :643-652
[9]   EMT: 2016 [J].
Angela Nieto, M. ;
Huang, Ruby Yun-Ju ;
Jackson, Rebecca A. ;
Thiery, Jean Paul .
CELL, 2016, 166 (01) :21-45
[10]   Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers [J].
Armstrong, Andrew J. ;
Marengo, Matthew S. ;
Oltean, Sebastian ;
Kemeny, Gabor ;
Bitting, Rhonda L. ;
Turnbull, James D. ;
Herold, Christina I. ;
Marcom, Paul K. ;
George, Daniel J. ;
Garcia-Blanco, Mariano A. .
MOLECULAR CANCER RESEARCH, 2011, 9 (08) :997-1007